News
Del-zota was granted FDA breakthrough therapy designation for treating DMD, and its developer is on track to seek its ...
A public workshop that columnist Shalom Lim and his girlfriend, Amanda, organized aimed to foster connection among people ...
Columnist Patrick Moeschen emphasizes the importance of making advance directives and shares some tips for how to get started ...
The FDA asked Sarepta to pause all U.S. shipments of the DMD gene therapy Elevidys, and the company has agreed after initially refusing.
While looking at a hotel mirror, columnist Betty Vertin reflects on the past 15 years of raising three sons with DMD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results